Bupropion/Naltrexone
Contrave · Mysimba
Ancillary GLP-1 Published Clinical Data
Overview
Combination of bupropion (norepinephrine/dopamine reuptake inhibitor) and naltrexone (opioid antagonist). FDA-approved for chronic weight management. Stacked with GLP-1 agonists in community protocols targeting food noise and cravings when GLP-1 alone is insufficient.
Used in Regimens
Bupropion/Naltrexone is not currently part of any catalog regimen.
Related Tools
Track Bupropion/Naltrexone with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.